Guilin Sidamaide Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Guilin Sidamaide Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PULSECORE. The owner is based in Guilin.

Room 1-5-03, Building 1, No. 36, Lidong Center, No. 36, Huancheng South 1st Road, Qixing District Street, Qixing District

Guilin 541000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PULSECORE
PULSECORE
Registered 2025

Trademark Classifications

Guilin Sidamaide Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Guilin Sidamaide Technology Co., Ltd. have?

Guilin Sidamaide Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guilin Sidamaide Technology Co., Ltd. file in?

Guilin Sidamaide Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Guilin Sidamaide Technology Co., Ltd.'s most well-known trademarks?

Guilin Sidamaide Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as PULSECORE. These are among 1 currently registered trademark in the portfolio.

What is Guilin Sidamaide Technology Co., Ltd.'s trademark registration success rate?

Guilin Sidamaide Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.